MARKET

EQRXW

EQRXW

Eqrx Inc
NASDAQ
0.2598
-0.0042
-1.59%
Closed 16:00 01/27 EST
OPEN
0.3791
PREV CLOSE
0.2640
HIGH
0.3800
LOW
0.2584
VOLUME
6.50K
TURNOVER
1.19K
52 WEEK HIGH
1.520
52 WEEK LOW
0.1034
MARKET CAP
--
P/E (TTM)
-0.8416
1D
5D
1M
3M
1Y
5Y
BRIEF-Softbank Group Corp Is Determined To Sell Some Or All Holdings Of Shares Of EQRX In Open Market
Reuters · 01/18 22:29
BRIEF-EQRx Inc Expects To Report That It Had About $1.4 Bln Of Cash, Cash Equivalents And Short-Term Investments As Of Dec 31, 2022
Reuters · 01/11 13:51
BRIEF-EQRx Reports Q3 Loss Of $0.18 Per Share
Reuters · 11/10/2022 13:34
BRIEF-EQRx reports Q2 results
BRIEF-EQRx reports Q2 results
Reuters · 08/11/2022 11:39
EQRx Reports Second Quarter 2022 Financial Results and Recent Corporate Progress
Initiated a U.S.-led, comparative Phase 3b clinical trial with aumolertinib for the first-line treatment of EGFR-mutated NSCLCAnnounced U.K. MHRA acceptance of EQRx’s first regulatory submission (aumolertinib) for review; first sugemalimab regulatory submi...
GlobeNewswire · 08/11/2022 11:00
EQRx Announces Late-Breaking Oral Presentation of Final Progression-Free Survival Results from Phase 3 Trial of Sugemalimab in Stage III Non-small Cell Lung Cancer at IASLC 2022 World Conference on Lung Cancer
In the ongoing GEMSTONE-301 Phase 3 study, sugemalimab, administered after treatment with either concurrent or sequential chemoradiotherapy, demonstrated a statistically significant improvement in progression-free survival versus placebo in patients with u...
GlobeNewswire · 08/07/2022 08:10
EQRx to Hold Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022
CAMBRIDGE, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices, today announced it will host a conference...
GlobeNewswire · 07/28/2022 12:00
Companies Like EQRx (NASDAQ:EQRX) Are In A Position To Invest In Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Simply Wall St. · 07/03/2022 12:22
More
About EQRXW
CM Life Sciences III Inc is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target. The Company intends to execute business combination in the life sciences sector.

Webull offers kinds of EQRx Inc stock information, including NASDAQ:EQRXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EQRXW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EQRXW stock methods without spending real money on the virtual paper trading platform.